Arkolith/Insider Trading/INBX/Form 4

Eckelman Brendan P.

Chief Scientific OfficerInhibrx, Inc. (INBX) · full profile →Form 4 · filed May 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 22, 2024Option exercise(M)3K$34.12$86K7K
May 22, 2024Option exercise(M)3K$34.12$85K27K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001739614-24-000033) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML